Literature DB >> 22170552

Significance of HPV 16 and 18 viral load quantitation in women referred for colposcopy.

Xavier Carcopino1, Mireille Henry, Julien Mancini, Sophie Giusiano, Léon Boubli, Daniel Olive, Catherine Tamalet.   

Abstract

The clinical utility of HPV 16 and 18 viral loads remains debated. The aim of this study was to assess the clinical significance of HPV 16 and 18 viral load and to determine a cut-off for optimal prediction of grade 2 or higher cervical intraepithelial neoplasia among patients referred to colposcopy. A total of 186 cervico-vaginal specimens harboring HPV 16 and/or 18 obtained at the time of colposcopy from patients without previous cervical neoplasia were tested for HPV 16 and 18 detection and quantitation using quantitative duplex real-time PCR method. Grade 2 or higher cervical intraepithelial neoplasia was diagnosed in 87 (46.8%) cases. Only HPV 16 median viral load increased significantly with the lesion grade: 9.1 × 10(4) in normal cervix or grade 1 cervical intraepithelial lesion versus 4.0 × 10(6) copies per million cells in grade 2 or higher cervical intraepithelial lesion (P < 0.001). The highest predictive value for grade 2 or higher cervical intraepithelial lesion was observed with a HPV 16 viral load cut-off of 3.0 × 10(6) copies per million cells (91% specificity, 58.2% sensitivity). Using this cut-off, the highest predictive value of HPV 16 viral load was observed among those referred for previous low-grade abnormal cervical cytology (96.4% specificity, 88% sensitivity). HPV 18 quantitation showed very poor predictive value. Specific attention should be given when performing colposcopic examination of women with an HPV 16 viral load higher than 3.0 × 10(6) copies per million cells, especially among those referred after a low-grade abnormal cytology.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22170552     DOI: 10.1002/jmv.23190

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  18 in total

Review 1.  Tumor markers of uterine cervical cancer: a new scenario to guide surgical practice?

Authors:  Gaetano Valenti; Salvatore Giovanni Vitale; Alessandro Tropea; Antonio Biondi; Antonio Simone Laganà
Journal:  Updates Surg       Date:  2017-09-16

2.  Association of HPV16 and 18 genomic copies with histological grades of cervical lesions.

Authors:  Negar Joharinia; Ali Farhadi; Seyed Younes Hosseini; Akbar Safaei; Jamal Sarvari
Journal:  Virusdisease       Date:  2019-07-22

3.  Comparison of GeneFinder human papillomavirus (HPV) Liquid Beads Microarray PCR Kit and Hybrid Capture 2 Assay for Detection of HPV Infection.

Authors:  Kiwoong Ko; Min-Jung Kwon; Eun Hee Lee; Hee-Yeon Woo; Hyosoon Park
Journal:  J Clin Lab Anal       Date:  2016-07-08       Impact factor: 2.352

4.  Comparison of AdvanSure HPV GenoBlot and Hybrid Capture 2 assays for detection of HPV infection.

Authors:  Kiwoong Ko; Shinae Yu; Min-Jung Kwon; Eun Hee Lee; Hee-Yeon Woo; Hyosoon Park
Journal:  J Clin Lab Anal       Date:  2017-02-15       Impact factor: 2.352

5.  Detection of HPV16 viral load in L2 gene as a related predictor of cervical cancer among women in Dhi-Qar province by qRT-PCR.

Authors:  Abduladheem Turki Jalil; Muhammad Usman Faryad Khan; Hayder Ali Muhammed; Ahmed Abdulhussein Kawen; Balsam Qubais Saeed; Aleksandr Karevskiy
Journal:  Mol Biol Rep       Date:  2022-10-10       Impact factor: 2.742

6.  Oxidative stress in HPV-driven viral carcinogenesis: redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues.

Authors:  Federico De Marco; Elona Bucaj; Cesira Foppoli; Ada Fiorini; Carla Blarzino; Kozeta Filipi; Alessandra Giorgi; Maria Eugenia Schininà; Fabio Di Domenico; Raffaella Coccia; D Allan Butterfield; Marzia Perluigi
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

7.  Comparison of the digene HPV genotyping LQ test and the PANArray HPV genotyping chip for detection of high-risk or probable high-risk human papillomavirus genotypes.

Authors:  Kyung Sun Park; Ji-Youn Kim; Chang-Seok Ki; Nam Yong Lee
Journal:  Ann Lab Med       Date:  2014-06-19       Impact factor: 3.464

8.  Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling.

Authors:  Yvonne Deleré; Cornelius Remschmidt; Josefine Leuschner; Melanie Schuster; Michaela Fesenfeld; Achim Schneider; Ole Wichmann; Andreas M Kaufmann
Journal:  BMC Infect Dis       Date:  2014-02-19       Impact factor: 3.090

9.  Protective vaccination against papillomavirus-induced skin tumors under immunocompetent and immunosuppressive conditions: a preclinical study using a natural outbred animal model.

Authors:  Sabrina E Vinzón; Ilona Braspenning-Wesch; Martin Müller; Edward K Geissler; Ingo Nindl; Hermann-Josef Gröne; Kai Schäfer; Frank Rösl
Journal:  PLoS Pathog       Date:  2014-02-20       Impact factor: 6.823

10.  Persistence, clearance and reinfection regarding six high risk human papillomavirus types in Colombian women: a follow-up study.

Authors:  Sara C Soto-De León; Luisa Del Río-Ospina; Milena Camargo; Ricardo Sánchez; Darwin A Moreno-Pérez; Antonio Pérez-Prados; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  BMC Infect Dis       Date:  2014-07-16       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.